Clinical trials
STEMI clinical trials
Below are recruiting stemi clinical trials, each written for real people, not researchers. We’re tracking 76 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06535503Recruiting
Heart attack with shock: Study of patient outcomes in Abu Dhabi
This study looks at the medical records of people who had a severe heart attack (STEMI) that caused cardiogenic shock. Researchers want to understand how these patients did during their hospital stay to improve care in the future.
Abu Dhabi, Abu Dhabi EmirateAges 18 years+ - NCT06536686Recruiting
Heart check during abdominal surgery study
This study checks for silent heart problems in people having abdominal surgery for non-cancer reasons. It aims to see if patients with a silent heart attack during surgery can be identified and helped.
LjubljanaAges 18 years+ - NCT06537583Recruiting
Ear stimulation after a STEMI heart attack
This study tests whether gentle electrical stimulation near your ear (tragus) can help stabilize your heart's rhythm and reduce inflammation after a STEMI heart attack. It may help lower the risk of future heart problems.
Semarang, Central of JavaAges 18–70 - NCT06564909RecruitingPhase 2
L-carnitine for heart muscle protection after a heart attack
This trial tests whether the supplement L-carnitine, given during a heart attack procedure, can reduce heart muscle damage. If you are having a STEMI heart attack and are getting angioplasty, you may be able to join.
CairoAges 18–75 - NCT06567249Recruiting
Cooling the heart during a heart attack procedure
This study tests whether cooling the heart with a cold liquid during a procedure (angioplasty) can help reduce damage after a heart attack. It may be an option for people who arrive at the hospital quickly after a heart attack.
TomskAges 18–90 - NCT06586424Recruiting
Can Anion Gap Predict Heart Risks After a Heart Attack?
This study checks if a simple blood test measure (anion gap) can help predict serious heart problems in people who have had a major heart attack (STEMI) and received emergency angioplasty. It may help doctors better understand your risk and guide future care.
Semarang, Central of JavaAges 18–70 - NCT06654453Recruiting
Clot removal during heart catheterization after clot-busting medicine
This study tests whether removing a clot with a special suction device during a heart catheterization helps people who already received a clot-busting medicine for a severe heart attack. It may improve blood flow and reduce damage to the heart muscle.
Changsha, HunanAges 18 years+ - NCT07362446RecruitingPhase 2
Study of a heart drug for first-time heart attack patients
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
Kingswood, New South WalesAges 40–75 - NCT06742125Recruiting
Drug balloon vs. stent for heart attack treatment
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
Hangzhou, ZhejiangAges 18 years+ - NCT06746233Recruiting
Balloon versus stent for heart attack treatment
This trial compares a drug-coated balloon to a drug-coated stent for opening blocked arteries during a heart attack. It aims to see which device works better for patients having a specific type of heart attack called STEMI.
Banja LukaAges 18 years+ - NCT06795035Recruiting
Coronary microvascular testing after heart attack
This study tests a way to measure tiny blood vessels in the heart after a major heart attack (STEMI) using a special catheter with salt water. The goal is to see if this test helps doctors understand how well your heart is healing.
Cleveland, OhioAges 18 years+ - NCT06885619Recruiting
Predicting heart outcomes after a first heart attack with blood tests
This study looks at blood tests and heart function after a first heart attack (STEMI) treated with emergency stenting. Researchers want to see if certain molecules in the blood can predict future heart problems.
Beijing, Beijing MunicipalityAges 18–80 - NCT06927791Recruiting
Using AI to spot heart problems earlier
This trial uses machine learning (a type of artificial intelligence) to help doctors diagnose acute heart or vessel conditions faster. It may lead to quicker treatment for patients with sudden heart problems.
BaselAges 18 years+ - NCT06951724Recruiting
New device to remove blood clots during a heart attack
This trial tests a special catheter designed to suction out blood clots from the heart's arteries during a heart attack. It may help restore blood flow and limit heart damage.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06956560Recruiting
Heart Scar Imaging Study for Heart Attack and Failure Patients
This study uses a special imaging agent to see a protein called PDGFRß in the heart, which may help detect scarring (fibrosis) after a heart attack or in heart failure. It aims to improve how we understand and treat heart muscle damage.
UppsalaAges 40–70 - NCT07026708Recruiting
Study of inflammation after heart attack
This study tracks inflammation in patients who had a heart attack and received a stent. It aims to understand inflammation levels after the event.
TiranaAges 18–85 - NCT07055152Recruiting
Eye scan to understand heart attack risk in MINOCA patients
This study uses a special eye scan (OCTA) to look at tiny blood vessels in the eye and see if they can help predict outcomes for people who had a heart attack without blocked arteries (MINOCA). It compares these patients to others with typical heart attacks and healthy people.
Pisa, PisaAges Any age - NCT05491200RecruitingPhase 4
Test shorter blood-thinner use versus standard after heart attack
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
BonheidenAges Any age - NCT07257198RecruitingPhase 3
Aspirin-free care with ticagrelor after a heart attack treated without stents or bypass
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
Montreal, QuebecAges 18 years+ - NCT07293832Recruiting
Beta-blocker therapy for heart attack patients
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Thessaloniki, ThessalonikiAges 18–80 - NCT07297589RecruitingPhase 3
CT scan of heart fat after heart attack
This study uses a CT scan to look at the layer of fat around the heart in people who recently had a heart attack and have type 2 diabetes and obesity. It aims to understand how this fat relates to inflammation and heart health.
León, GuanajuatoAges 18 years+ - NCT07366684Recruiting
Heart attack study for adults 75 and older
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
NišAges 75 years+ - NCT07380919RecruitingPhase 2/Phase 3
Study of ranolazine to prevent heart muscle damage after a heart attack
This trial tests whether a medication called ranolazine can help prevent damage to tiny blood vessels in the heart after a certain type of heart attack (STEMI). You may be eligible if you recently had this kind of heart attack and had a successful procedure to open a blocked artery, but still have other blockages that can be treated with stents.
Catanzaro, ItalyAges 18–80 - NCT02778724Recruiting
Heart catheterization registry for adults who had angioplasty
This study is a national registry that collects information from adults who had a heart catheter test (coronary angiogram) or a procedure to open blocked heart arteries (angioplasty). It helps doctors better understand how these procedures are used and what outcomes patients experience.
Le Coudray, Eure Et LoireAges 18 years+
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stemi?
- Yes. Clin2 currently lists 76 recruiting stemi studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stemi trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stemi trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.